Zura Bio Stock Quote ZURA - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

4.45

Bid

4.25

Ask

4.50

Volume

897,979

3.68 Day's Range 4.85

2.00 52 Week Range 14.00

Market Cap

191.812M

Previous Close

3.62

Open

3.68

Last Trade

4.45

Last Trade Time

Financial Volume

$ 3,946,485

VWAP

4.3949

Average Volume (3m)

303,146

Shares Outstanding

43,593,678

Dividend Yield

PE Ratio

-2.77

Earnings Per Share (EPS)

-1.59

Revenue

Net Profit

-69.24M

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutrali... Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California. Show more

Sector

Lab Analytical Instruments

Industry

Blank Checks

Website

zurabio.com

Headquarters

Grand Cayman, Cym

Founded

2023

Zura Bio Ltd is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker ZURA. The last closing price for Zura Bio was $3.62. Over the last year, Zura Bio shares have traded in a share price range of $ 2.00 to $ 14.00.

Zura Bio currently has 43,593,678 shares outstanding. The market capitalization of Zura Bio is $191.81 million. Zura Bio has a price to earnings ratio (PE ratio) of -2.77.

Zura Bio Announces Oversubscribed $112.5 Million Private Placement

- Financing includes new and existing leading life sciences institutional investors - Strengthened balance sheet expected to fund operations through 2027 Zura Bio Limited (Nasdaq: ZURA) (“Zura...

Zura Bio Announces Robert Lisicki as CEO and Director

- Succeeds Founding CEO, Dr. Someit Sidhu, who will continue as a Board Director - Recognized as inspirational industry leader with exceptional R&D, commercial and global executive experience...

Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer

Significant 2023 milestones highlighted by successful Nasdaq listing, leadership team buildout, formation of strategic development and scientific plan On track to initiate Phase 2 study...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.8	21.9178082192	3.65	4.85	3.13	327961	3.38722476	CS
4	2	81.6326530612	2.45	4.85	2.4157	269936	3.26385269	CS
12	1.31	41.7197452229	3.14	4.85	2	303146	2.90668919	CS
26	-0.9	-16.8224299065	5.35	5.5	2	245270	3.50567966	CS
52	-3.43	-43.5279187817	7.88	14	2	339276	5.94994183	CS
156	-3.55	-44.375	8	37.55	2	338945	7.84734721	CS
260	-3.55	-44.375	8	37.55	2	338945	7.84734721	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.3254 (82.86%)	70.82M
IBRXImmunityBio Inc	$ 7.35 (43.84%)	40.28M
AGENAgenus Inc	$ 11.685 (40.78%)	3.37M
ULHUniversal Logistics Holdings Inc	$ 45.63 (38.74%)	484.22k
NIVFNewGenIvf Group Ltd	$ 1.77 (36.15%)	57.78M
MFImF International Ltd	$ 2.3153 (-77.82%)	21.23M
NWGLNature Wood Group Ltd	$ 5.05 (-70.03%)	2.48M
ICLKiClick Interactive Asia Group Ltd	$ 1.21 (-52.17%)	719.95k
NUWENewellis Inc	$ 0.1695 (-41.35%)	18.46M
SGBXSafe and Green Holdings Corporation	$ 0.1469 (-32.92%)	8.39M
PEGYPineapple Energy Inc	$ 0.065499 (26.20%)	325.57M
SQQQProShares UltraPro Short QQQ	$ 11.43 (-4.75%)	137.28M
INTCIntel Corporation	$ 31.88 (-9.20%)	119.84M
TSLATesla Inc	$ 168.29 (-1.11%)	109.84M
SOFISoFi Technologies Inc	$ 7.87 (3.69%)	88.63M